Tungsten E2's Ease of Use, Long Battery Life and Non-volatile Memory Provides
Secure, Accurate Capture of Clinical Trial Data in the Field
MILPITAS, Calif., April 13 /PRNewswire-FirstCall/ -- palmOne, Inc.
(Nasdaq: PLMO) today announced that invivodata(R) inc., an industry leader in
electronic patient reported outcome (PRO) solutions for clinical research, has
plans to deploy between 5,000 and 7,000 Tungsten(TM) E2 handhelds from palmOne
for use in worldwide clinical trials during the next 90 days. As the demand
for invivodata's unique electronic diary system, DiaryPRO(TM) continues to
grow, the number of deployed devices could easily be four times that amount by
the end of 2005.
[NOTE: See today's related release from palmOne, "palmOne Introduces
Sleek, Stylish Tungsten E2 Handheld."]
By combining behavioral science and clinical expertise with palmOne's
proven handheld technology, invivodata's electronic diary system increases
patient compliance with reporting requirements to more than 90 percent, up
from less than 20 percent with conventional paper-based diaries(1). This
dramatic increase in compliance delivers higher-integrity PRO data that trial
sponsors can rely upon as they evaluate the effectiveness of new treatments.
In fact, invivodata's electronic diary has successfully delivered key data for
multiple new drug approvals granted by the Food and Drug Administration (FDA).
"By deploying our scientific expertise on palmOne's newest handheld
product, we will continue to deliver unique solutions that streamline the
clinical drug development process and put patients back at the center of
research where they belong," said Doug Engfer, president and chief executive
officer of invivodata. "We look forward to standardizing on the Tungsten E2 as
our device of choice and leveraging its flexibility and ease of use in
clinical trials throughout the world."
The Tungsten E2 builds on the popularity of the Tungsten E handheld, which
has sold nearly 2 million units worldwide. The Tungsten E2's non-volatile
memory and Bluetooth(R) technology are key enablers for clinical trial use.
While non-volatile memory keeps trial data secure, Bluetooth technology
enables integration with physiological devices, such as peak flow meters, a
standard tool used in respiratory trials.
"With the ever-increasing importance being placed on high-quality patient-
reported data, we answered our customers' demand by delivering a handheld
computer with non-volatile, flash memory to keep all information on the
product safe, even if there's no time to recharge," said Tara Griffin, vice
president, Americas Sales, for palmOne. "It's rewarding to see how invivodata
and its pharmaceutical, biotech and medical device company clients will
benefit from all of the Tungsten E2's new features."
About invivodata inc.
invivodata ( http://www.invivodata.com ) combines behavioral science,
information technology and clinical expertise to capture clinical trial data
of the highest integrity directly from patients. invivodata's electronic
patient reported outcomes (PRO) system delivers high-quality patient self-
reported data by driving patient compliance with the protocol and eliminating
recall biases that plague self-report studies. The invivodata solution, which
includes DiaryPRO(TM) for real-time PRO data collection and SitePRO(TM) for
site-based PRO data collection, provides access to study data, giving
researchers and sponsors visibility into study progress and improving trial
efficiencies. invivodata's solution has been used in more than 100 trials
involving over 35,000 patients. It has also collected nearly 50 million
patient-initiated records, and is the only eDiary system that has delivered
primary efficacy data for FDA drug approvals. invivodata inc. is a privately
held company with global headquarters in Pittsburgh, Pa., USA; its European
headquarters are in London, England; and its technology development center is
in Scotts Valley, Calif., USA.
About palmOne, Inc.
palmOne, Inc. -- a leader in handheld computing and communications
solutions -- strives to put the power of computing in people's hands so they
can access and share their most important information. The company's products
include Treo(TM) smartphones, Zire(TM) and Tungsten(TM) handhelds, and
software and accessories.
palmOne products are sold through select Internet, retail, reseller and
wireless operator channels throughout the world, and at palmOne Retail Stores
and palmOne online stores ( http://www.palmOne.com/stores ).
More information about palmOne, Inc. is available at
http://www.palmOne.com .
(1) British Medical Journal, Volume 324, May 18, 2002
NOTE: palmOne, Tungsten, Zire and Treo are among the trademarks or
registered trademarks owned by or licensed to palmOne, Inc. or its
subsidiaries. The Bluetooth word mark and logos are owned by the Bluetooth
SIG, Inc. and any use of such marks by palmOne, Inc. is under license. All
other brand and product names are or may be trademarks of, and are used to
identify products or services of, their respective owners.
SOURCE palmOne, Inc.
04/13/2005
CONTACT: Erin Freeley of A&R Partners, +1-650-762-2863, or
efreeley@arpartners.com, for palmOne, Inc.
Web site: http://www.invivodata.com
Web site: http://www.palmone.com